One in Five Idiopathic Pulmonary Fibrosis Deaths May Be Due to Occupational Exposures

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on March 8, 2025.

By Lori Solomon HealthDay Reporter

FRIDAY, March 7, 2025 -- Roughly one in five (21 percent) of idiopathic pulmonary fibrosis (IPF) deaths might be related to occupational exposures, according to research published in the March 6 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Jacek M. Mazurek, M.D., from the National Institute for Occupational Safety and Health in Washington, D.C., and colleagues conducted an exploratory analysis of 2020 to 2022 multiple cause-of-death data to examine IPF mortality among U.S. workers by industry and occupation.

The researchers identified 67,843 decedents with IPF (59 percent male), suggesting that during this three-year period, 8,340 IPF deaths in men and 5,908 deaths in women might have been associated with occupational exposures. The highest proportionate mortality ratios by industry group were among those employed in utilities for men (1.15) and those employed in public administration for women (1.12). The highest IPF mortality rates by occupation group among men were for community and social services workers (1.23); for women, the occupation group with the highest IPF mortality rates was farming, fishing, and forestry workers (1.24).

"Estimates of elevated IPF mortality among workers in specific industries and occupations warrant confirmation, control of known exposure-related risk factors, and continued surveillance to better understand the full range of occupational exposures that might increase risk for developing IPF," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-03-08 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords